TinyGemsBreaks Archive - Page 38 of 144

FridayAug 02, 2024 10:53 am

TinyGemsBreaks – Better Choice Company (NYSE American: BTTR) Closes on $5M Public Offering

Better Choice Company (NYSE American: BTTR), a pet health and wellness company, has closed on its public offering. The offering consisted of 639,000 shares of common stock as well as prefunded warrants to purchase 1,028,000 shares of its common stock. According to the announcement, each share of common stock and prefunded warrant was sold at $3 per share (inclusive of the prefunded warrant exercise price), resulting in gross proceeds of approximately $5 million, before underwriting discounts and offering expenses were deducted. The announcement also noted that Better Choice granted the underwriters a 45-day option to purchase up to an additional…

WednesdayJul 31, 2024 1:50 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) to Participate as an Anchor Organization at the 2024 Southeastern United States – Canadian Provinces Business Forum

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is participating as an Anchor Organization and panelist at the 2024 Southeastern United States - Canadian Provinces (“SEUS-CP”) Business Forum. The 2024 SEUS-CP is set to take place August 4-6 in Biloxi, Mississippi; Mississippi is home to Mullen’s commercial EV manufacturing. Mullen is a confirmed Anchor Organization at the event alongside other companies. According to the announcement, this year’s business forum focuses on Advanced Manufacturing (Aerospace and Electric Vehicle Technologies and Components) and the Blue Economy (Shipbuilding, UAVs, Smart Ports Energy, Innovative Materials, Innovative Technologies & Data Analytics, Fisheries &…

TuesdayJul 30, 2024 11:48 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Long-Term Study Results Confirm Positive Results of Developing Treatment for AD

InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, is reporting on positive results from a long-term study of INM-901. The in vivo preclinical Alzheimer's disease (“AD”) involved seven months of dosing and confirms findings from an earlier short-term pilot study. The company reported that results from the study confirm improvements in cognitive function, memory and locomotor activity and show statistical significance in certain behavioral assessments.According to the announcement, InMed is moving forward with additional molecular analyses to better define the mechanisms of action and…

TuesdayJul 30, 2024 10:32 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBM

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered into an exclusive license agreement with Cortice Biosciences Inc. Through the agreement, CNS Pharmaceuticals has acquired a license as well as the intellectual property rights to a potentially blood-brain-barrier, permeable microtubule inhibitor called TPI 287. The inhibitor is being developed for the treatment of glioblastoma multiforme (“GBM”). In return for the license, CNS Pharmaceuticals will pay Cortice an up-front payment of 616,698 shares of its common stock, as well as the possibility…

MondayJul 29, 2024 1:51 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Receives Order for Mullen Campus EVs from Leading Transportation and Logistics Company

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has received an order for four Mullen Campus electric vehicles from DB Schenker, one of the world’s leading transportation and logistics companies. According to the announcement, the vehicles will be used for mail and delivery on Intel’s technology campus in Chandler, Arizona. The order was received through one of Mullen’s commercial vehicle dealers, Randy Marion Automotive. The dealer has received payment for the vehicles, and the vehicles have been delivered to DB Schenker. According to the company, the Mullen Campus is a highly efficient electric van designed for low-speed, closed-campus use.…

MondayJul 29, 2024 12:58 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Enters Definitive Agreement to Embark on New Journey Together with Koito

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high performance lidar solutions, is announcing the signing of a definitive agreement. The agreement provides for the acquisition of Cepton by Koito Manufacturing Co. Ltd. (TSE: 7276), a leading automotive tier one supplier. Specifically, Koito will acquire all the outstanding capital stock of Cepton not owned by itself in an all-cash transaction, with Cepton stockholders receiving $3.17 per share in cash. According to the announcement, the proposed transaction has been approved by each company’s Board of Directors and recommended to Cepton’s stockholders by Cepton’s Board of Directors. It is expected…

WednesdayJul 24, 2024 12:24 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Receives PO from European Distributor for 29 Mullen GOs

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has received an order for 29 Mullen GOS from one of its newest European distribution partners. The order for the GOs, which are Mullen’s commercial micro-urban-delivery vehicle, came from GAMA, which is a distribution partner covering southeast Europe, including the Balkans Region. The order from GAMA, which is valued at $304,000, is part of a previously announced 53-unit commercial vehicle order; that order is for urban delivery vehicles as well as Mullen One and Mullen Three commercial EV cargo vans and trucks, which have not yet been delivered. The compact design…

TuesdayJul 23, 2024 10:52 am

TinyGemsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Subsidiary Announces Warranty Coverage for B4 Chassis Cab

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced that its subsidiary, Bollinger Motors, released its full warranty coverage on the Bollinger B4 Chassis Cab, the company’s all-new, all-electric Class 4 commercial truck. “We have designed and engineered the Bollinger B4 to have unmatched capability and durability, and we are proud to be offering warranty coverage to reflect that,” said Jim Connelly, chief revenue officer of Bollinger Motors. “Our warranty provides our customers the peace of mind they need in making their decision and demonstrates the confidence we have in the B4.” To view the full press…

ThursdayJul 18, 2024 2:58 pm

TinyGemsBreaks – GEMXX Corp. (GEMZ) Capitalizing on High-Potential Opportunities in Energy Sector

GEMXX (OTC: GEMZ), a publicly traded exploration company engaged in gold, gemstones, oil and gas, recently signed a definitive agreement with Latin Energy Partners (“LEP”) to drill four test wells in a promising geological formation in Latin America. “This strategic venture represents a significant milestone in GEMXX’s expansion into the energy sector, highlighting the company’s dedication to diversification, growth and enhancing shareholder value. Latin Energy Partners is a rising independent exploration and production company focused on discovering substantial hydrocarbon reserves in Latin America, an area with significant untapped potential… The drilling of the four test wells is set to begin…

WednesdayJul 17, 2024 3:23 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Noteworthy Findings from Interim Results of Ongoing Diabetes Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the receipt of interim results from the first four weeks of dosing in its ongoing diabetes animal study WEIGHT-A24-1. The company noted that the results have already produced several noteworthy findings. According to the announcement, unlimited food and water have been provided to the animals for the entire duration of the study. During the initial acclimation phase, which spanned 34 days before the beginning of dosing, the animals gained 10.9% body weight on average. During the subsequent 28 days of DehydraTECH-processed drug therapy dosing, all test…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks